Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_assertion type Assertion NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_head.
- NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_assertion description "[Thus, NF-kappaB inhibitors may open new perspectives to potentiate the efficacy of TRAIL-based protocols in the treatment of neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_provenance.
- NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_assertion evidence source_evidence_literature NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_provenance.
- NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_assertion SIO_000772 19065652 NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_provenance.
- NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_assertion wasDerivedFrom befree-20150227 NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_provenance.
- NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_assertion wasGeneratedBy ECO_0000203 NP804279.RAxlu7AeAOL7hpfVmCIKpg0YY-gfa66V7Jdk1TNkn9JVQ130_provenance.